Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pasquier

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 6, 2018
In Reply to El Majjaoui et alDavid Pasquier
International Journal of Radiation Oncology, Biology, Physics|October 29, 2008
Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature reviewDavid Pasquier, Charles Ballereau
European Urology Oncology|December 2, 2023
Reply to Nikolaos Grivas, Christos Zampaftis, Dimitris Ermidis, Ioannis Leotsakos, Ioannis Katafigiotis, and Markos Karavitakis's Letter to the Editor re: David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al. The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study. Eur Urol Oncol 2023;6:399-405David Pasquier, Thomas Lacornerie
Bulletin Du Cancer|July 15, 2003
[Anemia and radiotherapy]David Pasquier, Eric Lartigau
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2011
MRI prostate radiation therapy planning: when the patient distorts his own image (Regarding Lambert et al., Radiother Oncol 2011; 98: 330-334)David Pasquier, Eric Lartigau
The Lancet. Oncology|November 27, 2025
SBRT in oligometastatic castration-resistant prostate cancerVérane Achard, Pierre Blanchard, David Pasquier, et al.
European Neurology|April 15, 2008
Bilateral thalamic metastases in endometrial adenocarcinomaCarole Ramirez, Nicolas Reyns, David Pasquier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 7, 2025
Breast cancer tumour board: Which patients are eligible for radiotherapy de-escalation or omission?Joran Hibon, Waisse Waissi, David Pasquier, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|February 16, 2005
Segmentation of abdominal ultrasound images of the prostate using a priori information and an adapted noise filterNacim Betrouni, Maximilien Vermandel, David Pasquier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 30, 2025
Quality assurance of contouring and dosimetric consistency in the GETUG-AFU 31 salvage prostate stereotactic reirradiation trialMarion Tonneau, Clarisse Bartau, Thomas Lacornerie, et al.
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
International Journal of Radiation Oncology, Biology, Physics|April 6, 2018
In Reply to El Majjaoui et alDavid Pasquier
International Journal of Radiation Oncology, Biology, Physics|October 29, 2008
Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature reviewDavid Pasquier, Charles Ballereau
European Urology Oncology|December 2, 2023
Reply to Nikolaos Grivas, Christos Zampaftis, Dimitris Ermidis, Ioannis Leotsakos, Ioannis Katafigiotis, and Markos Karavitakis's Letter to the Editor re: David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al. The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study. Eur Urol Oncol 2023;6:399-405David Pasquier, Thomas Lacornerie
Bulletin Du Cancer|July 15, 2003
[Anemia and radiotherapy]David Pasquier, Eric Lartigau
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2011
MRI prostate radiation therapy planning: when the patient distorts his own image (Regarding Lambert et al., Radiother Oncol 2011; 98: 330-334)David Pasquier, Eric Lartigau
The Lancet. Oncology|November 27, 2025
SBRT in oligometastatic castration-resistant prostate cancerVérane Achard, Pierre Blanchard, David Pasquier, et al.
European Neurology|April 15, 2008
Bilateral thalamic metastases in endometrial adenocarcinomaCarole Ramirez, Nicolas Reyns, David Pasquier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 7, 2025
Breast cancer tumour board: Which patients are eligible for radiotherapy de-escalation or omission?Joran Hibon, Waisse Waissi, David Pasquier, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|February 16, 2005
Segmentation of abdominal ultrasound images of the prostate using a priori information and an adapted noise filterNacim Betrouni, Maximilien Vermandel, David Pasquier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 30, 2025
Quality assurance of contouring and dosimetric consistency in the GETUG-AFU 31 salvage prostate stereotactic reirradiation trialMarion Tonneau, Clarisse Bartau, Thomas Lacornerie, et al.
Pageof 16